Autoimmune thrombocytopenic purpura Clinical Trials
Conditions / Autoimmune thrombocytopenic purpura
Delta Trials records 5 clinical trials for Autoimmune thrombocytopenic purpura in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 11 study locations around the world. An additional 4 trials are active but not currently open for enrollment. Since 2020, 2 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
5
Total Trials
0
Recruiting
1
Completed
4
Other Active
2
Terminated since 2020
11
Study Locations
Browse by location (11 total)
- Metairie, United States 2 trialsAll trials in Metairie, United States
- Minneapolis, United States 1 trialAll trials in Minneapolis, United States
- Goshen, United States 1 trialAll trials in Goshen, United States
- Tucker, United States 1 trialAll trials in Tucker, United States
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States
- Buffalo, United States 1 trialAll trials in Buffalo, United States
- New York, United States 1 trialAll trials in New York, United States
- Vicenza, Italy 1 trialAll trials in Vicenza, Italy
- Riverdale, United States 1 trialAll trials in Riverdale, United States
- Denville, United States 1 trialAll trials in Denville, United States
- Créteil, France 1 trialAll trials in Créteil, France
- Créteil, France 1 trialAll trials in Créteil, France